Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_869_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
36 Мб
Скачать
16 The Evolution ofRobotic TAMIS
Fig. 16.4 2012: The rst robotic transanal excision of a neoplasm in a human. The da Vinci Si platform was used in conjunction with the GelPOINT Path Transanal Access Platform, the lesions were completely excised, and the defect reapproximated robotically using barbed absorbable suture. Note the patient’s modied Lloyd-Davies position and the docking of the cart over the right shoulder
Table 16.1 Chronological publications on robotic TAMIS
Author Date Country Interface Model n Remarks Atallah [27] September
Atallah [36] May 2012 USA GelPOINT Human 1 1st robotic TAMIS in a human Hompes [33] May 2012 UK Glove Cadaver 2 1st report of glove as interface for
Bardakcioglu [37]
Atallah [47] June 2013 USA GelPOINT Human 1 1st robotic taTME in a human Valls [42] August
Buchs [38] August
Hompes [40] April 2014 UK Glove Human 16 Atallah [48] June 2014 USA GelPOINT Human 3 1st pilot series on robotic taTME Gómez-Ruiz
[49] Atallah [41] February
Atallah [50] May 2015 USA GelPOINT
Kuo [51] October
Gómez-Ruiz [46]
Erenler [45] April 2017 Turkey GelPOINT Human 1 1st published case using Xi
Marks [35] July 2017 USA GelPOINT Cadaver 12 1st preclinical series with da Vinci
Atallah [50] October
2011
December 2012
2013
2013
January 2015
2015
2016 December
2017
2017
USA GelPOINT Cadaver 2 1st experiment with robotic
USA GelPOINT Human 1 2nd robotic TAMIS in a human to
Spain Glove Human 1
Switzerland Glove Human 3 1st description of the lateral
Spain Custom Human 5 Totally robotic (above and below)
USA GelPOINT Human 18 Includes local excision, stula
LoneStar
Taiwan GelPOINT Human 15 Single port+1 combined with
Spain Custom Human 9 da Vinci Si utilizing specialized
USA Flex robot
port
Human 1 1st report of robotic taTME with
Cadaver 2 1st preclinical report utilizing
TAMIS
transanal robotic access
be reported
approach
taTME
repair, taTME
robotic ISR
robotic taTME
hybrid port
platform
SP
exible robotic system for TAMIS and taTME
157
158
Fig. 16.5 Local excision via robotic TAMIS. 8 mm wristed, instrumented, and stereoscopic magnied optics are among the perceived advantages of the robotic plat­form. Here, rectal neoplasm boarders have been delin­eated with cautery marks, and a full-thickness excision is in progress. A Maryland grasper and hook cautery are the only instruments required to complete the excision
S. Atallah et al.
TAMIS remains limited, with mostly single­surgeon retrospective series reported in the litera­ture [39].
Docking andConguration
Today, docking of the multi-arm da Vinci robotic cart can be performed in various methods and is often predicated by surgeon preference, as well as the specic platform’s design and interface. For S and Si platforms, with the patient in dorsal lithotomy, cart docking can be parallel and ush against the operating table (Fig.16.6) or tangen­tially with the robotic arms delivered over the shoulder. In general, the Xi® system with its long
Fig. 16.6 Docking and patient conguration is often dependent on the specic robotic platform, the type of TAMIS port or glove port, and sometimes the position of the lesion. Surgeons who perform robotic TAMIS may also have a specic preference; although for robotic TAMIS (as compared to conventional TAMIS), there is more likely to be position and docking variability.
Notwithstanding, one of the most common congurations of the da Vinci Si systems with GelPOINT Path Transanal Access Platform is shown. Note that the robotic cart is docked ush with the operating table and working arms one and two are delivered over the thigh to prevent encroachment and collision during robotic TAMIS. The patient is typically positioned in steep Trendelenburg
16 The Evolution ofRobotic TAMIS
Fig. 16.7 The Xi® system has been docked orthogonally to the operating table, and the patient’s steep Trendelenburg, Lloyd­Davies position is evident. The low-prole arms and large wingspan of the Xi system allow for improved transanal access with less collision. Compared to the Si, however, 5mm effector arm instrumenta­tion is not (currently) available representing a potential limitation since, in general, it is advanta­geous to have small diameter instruments so as not to restrict workspace
®
arm span and low-prole conguration, provides more leeway in cart-to-patient arrangement. Common approaches using the Xi® system include perpendicular docking relative to the side of the operating table (Fig.16.7), but other options are valid.
While TAMIS is almost always performed with the patient in dorsal lithotomy, robotic TAMIS may or may not require the patient to be positioned in this fashion. Indeed, other patient positioning may be desirable. For example, anterior lesions are best approached with the patient positioned prone jack-knife. The advantage here is that the lower extremi­ties do not collide with the working arms dur­ing the process of dissection, leaving the effector arms with less likelihood for collision (Fig.16.8).
In the spring of 2014, the da Vinci Xi
®
was introduced, providing signicant advantages for the operator, especially regarding versatility with docking. The rst robotic TAMIS utilizing the Xi® platform was believed to have been per­formed on July 28, 2015 by S.Atallah (Fig.16.9). The rst published report using the Xi® was reported in a video vignette by Erenler etal. in 2017 [45]. The Xi® platform allows for various options in docking, and some experts prefer the prone jack-knife position with orthogonal cart
159
Fig. 16.8 Common conguration for robotic TAMIS using the Xi pneumatics. Here, an anterior distal rectal lesion is tar­geted for local excision. Two working arms and a 30° 8 mm lens are mated to the TAMIS port. Note that the GelPOINT Path Transanal Access Platform (TAMIS port) is suspended by the hooks of the Lone Star Retractor, which allows the access channel sleeve to be only partly admitted into the anal canal. This allows for improved dis­tal access for low-lying lesions
®
system is adapted with 5mm AirSeal for
160
S. Atallah et al.
Fig. 16.9 July 28, 2015: The rst robotic TAMIS using
®
the Xi
system was performed by S.Atallah in Orlando, FL, USA. The lesion was a 2.8 cm adenoma and was excised with negative margins. Note the conguration of the working arms with a 30° downward lens placed superi­orly and equidistant to two 8mm working arms. An addi­tional 5mm AirSeal port (ConMed, Inc., Utica, NY, USA) was used to provide stable pneumorectum. This fourth port allows for access of 5mm instruments (such as a suction irrigator) which can be operated by a bedside assistant
positioning for anterior rectal wall pathology. Another option is the lateral approach, which when combined with a glove port results in improved robotic arm excursion, as demon­strated by N.Buchs in 2013 with the Si system [38]. Furthermore, Gómez-Ruiz et al. have described the use of a specialized interface in which the platform is part rigid and bedrail mounted and part reusable. The rigid portion is similar to a 40mm dia. TEM scope, but the face­plate utilizes an 80 mm GelPOINT membrane that is twice the diameter of the standard TAMIS port (Fig.16.10). This likely allows for improved instrument maneuverability, decreased arm col­lisions, and a simplication of the port-to-robot rendezvous.
Fig. 16.10 A custom- made port, developed by Marcos Gómez-Ruiz, MD, is a hybrid cross between a TEM scope and a TAMIS port. The rigid reusable portion of the device is secured to the bedrail with a mount to hold it in posi­tion. The faceplate (disposable) is an 80mm GelPOINT (Applied Medical, Inc.). The conguration improves ergonomics and decreases collisions between working arms
Applications ofRobotics Beyond Local Excision
In 2013, just 3years after the rst reported human case of taTME by P.Sylla and A.Lacy, robotic taTME was successfully performed on a human for the rst time [54]. The patient was an obese female with familial adenomatous polyposis (FAP) syndrome and synchronous hepatic exure and rectal cancers. The abdominal resection was performed laparoscopically, and the taTME was performed by docking the da Vinci Si transanally with GelPOINT Path Access Platform as an inter­face. While there were limitations of reach, the robotic taTME was successfully completed in 87 min; the mesorectal envelop contained one
16 The Evolution ofRobotic TAMIS
161
defect measuring 1.5 cm and therefore was graded as a Quirke II (near complete); all mar­gins were negative [54].
While limited to expert centers, small series and pilot studies on robotic taTME have been pub­lished in both the preclinical and clinical settings [4749, 51, 55, 56], each series concluding that high-quality excision is feasible with the robotic platform (Fig. 16.11). Although most robotic approaches to taTME have applied the platform transanally in conjunction with laparoscopy for the abdominal portion of the operation, Marcos Gómez-Ruiz has used a totally robotic approach by double docking abdominally and then subse­quently transanally [49]. This technique utilizes a specialized platform that is a hybrid between TEM and TAMIS with some components reusable and others disposable, as described previously.
There has been an accelerated advancement in minimally invasive approaches to transanal sur­gery over recent years (Fig. 16.12). Robotic approaches are continuing to evolve with several new venders rapidly lling the space with cre­ative systems that, instead of mimicking laparos­copy, are being designed with computerized, remodeled mechanics that provide improved exibility and thus an ability to access anatomic targets not previously believed possible [50, 57]. Today, much of the focus on robotic transanal
surgery is toward the development of taTME, with the objective of improving the operative approach and reducing the challenges of conven­tional instrumentation [5860]. Image-guided surgery in conjunction with robotics for complex surgical procedures, such as taTME, is also an area actively being investigated. Robotic taTME is discussed further in Chap. 44.
Fig. 16.11 Robotic taTME represents the next step in the evolution of advanced, robotic transanal access. Here the da Vinci Si platform with a 5mm hook monopolar cautery and 5mm grasper is used to initiate the posterior TME dissection. The theoretical advantage of the robotics in a conned space is the potential to improve resection qual­ity by providing a platform with superior optics, magni­cation, and surgeon control
2012 : First Glove Port
for Robotics TAMIS
2011 : First Robotic
TAMIS Cadaveric
Experimentation
2013: First
Robotic taTME
2012: First
Robotic TAMIS
in a human
2017 : First Cadaveric Report using SP System
2015: First Xi
System for
robotic TAMIS
2017: First
Robotic TAMIS
and taTME
(Cadaveric)
With Flexible
Roboitc System
®
1984: TEM Developed
2001: First Robotic
Prostatectomy
2001: Transcontinental
Robotic Surgery
~1999: Sugical
Robotics Introduced
2002: First
Robotic
Colectomy
2009 : First
TAMIS
2009 : First
Abdominal Robotic
Single Port Surgery
2010: First
Robotic Transanal
Surgery Dry Lab
Experiments
Fig. 16.12 Timeline delineating the milestones in robotics in colorectal surgery including transanal approaches
162
S. Atallah et al.

References

1. Marescaux J, Leroy J, Rubino F, Smith M, Vix M, Simone M, Mutter D.Transcontinental robot-assisted remote telesurgery: feasibility and potential applica­tions. Ann Surg. 2002;235(4):487.
2. Marescaux J, Leroy J, Gagner M, Rubino F, Mutter D, Vix M, Butner SE, Smith MK.Transatlantic robot­assisted telesurgery. Nature. 2001;413(6854):379.
3. Kappert U, Cichon R, Schneider J, Gulielmos V, Tugtekin SM, Matschke K, Schramm I, Schueler S.Closed-chest coronary artery surgery on the beat­ing heart with the use of a robotic system. J Thorac Cardiovasc Surg. 2000;120(4):809–11.
4. Falk V, Diegler A, Walther T, Autschbach R, Mohr FW. Developments in robotic cardiac surgery. Curr Opin Cardiol. 2000;15(6):378–87.
5. Chitwood WR, Nifong LW, Elbeery JE, Chapman WH, Albrecht R, Kim V, Young JA. Robotic mitral valve repair: trapezoidal resection and pros­thetic annuloplasty with the da Vinci surgical system. J Thorac Cardiovasc Surg. 2000;120(6): 1171–2.
6. Mohr FW, Falk V, Diegeler A, Walther T, Gummert JF, Bucerius J, Jacobs S, Autschbach R.Computer­enhanced “robotic” cardiac surgery: experience in 148 patients. J Thorac Cardiovasc Surg. 2001;121(5): 842–53.
7. Zenati MA. Robotic heart surgery. Cardiol Rev. 2001;9(5):287–94.
8. Binder J, Kramer W.Robotically-assisted laparoscopic radical prostatectomy. BJU Int. 2001;87(4):408–10.
9. Pasticier G, Rietbergen JB, Guillonneau B, Fromont G, Menon M, Vallancien G.Robotically assisted lapa­roscopic radical prostatectomy: feasibility study in men. Eur Urol. 2001;40(1):70–4.
10. Abbou CC, Hoznek A, Salomon L, Olsson LE, Lobontiu A, Saint F, Cicco A, Antiphon P, Chopin D.Laparoscopic radical prostatectomy with a remote controlled robot. J Urol. 2001;165(6):1964–6.
11. Weber PA, Merola S, Wasielewski A, Ballantyne GH. Telerobotic-assisted laparoscopic right and sigmoid colectomies for benign disease. Dis Colon Rectum. 2002;45(12):1689–96.
12. Talamini M, Campbell K, Staneld C. Robotic gastrointestinal surgery: early experience and sys­tem description. J Laparoendosc Adv Surg Tech. 2002;12(4):225–32.
13. Baek SJ, Kwak JM, Kim J, Kim SH, Park S, Korean Association of Robotic Surgeons (KAROS) Study Group. Robotic rectal surgery in Korea: analysis of a nationwide registry. Int J Med Robot. 2018; https://
doi.org/10.1002/rcs.1896. [Epub ahead of print].
14. Kwak JM, Kim SH.Robotic surgery for rectal cancer: an update in 2015. Cancer Res Treat. 2016;48(2):427–
35. https://doi.org/10.4143/crt.2015.478. Epub 2016 Feb 3.
15. Ngu JC, Tsang CB, Koh DC. The da Vinci Xi: a review of its capabilities, versatility, and potential
role in robotic colorectal surgery. Robot Surg Res Rev. 2017;4:77–85. https://doi.org/10.2147/RSRR.
S119317.
16. Kim J, Baek SJ, Kang DW, Roh YE, Lee JW, Kwak HD, Kwak JM, Kim SH.Robotic resection is a good prognostic factor in rectal cancer compared with laparoscopic resection: long-term survival analy­sis using propensity score matching. Dis Colon Rectum. 2017;60(3):266–73. https://doi.org/10.1097/
DCR.0000000000000770.
17. Yoo BE, Cho JS, Shin JW, Lee DW, Kwak JM, Kim J, Kim SH.Robotic versus laparoscopic inter­sphincteric resection for low rectal cancer: compar­ison of the operative, oncological, and functional outcomes. Ann Surg Oncol. 2015;22(4):1219–25.
https://doi.org/10.1245/s10434-014-4177-5. Epub
2014 Oct 18.
18. Baek SJ, Kim CH, Cho MS, Bae SU, Hur H, Min BS, Baik SH, Lee KY, Kim NK.Robotic surgery for rec­tal cancer can over- come difculties associated with pelvic anatomy. Surg Endosc. 2015;29(6):1419–24.
https://doi.org/10.1007/s00464-014-3818-x.
19. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J.Effect of robotic- assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer. JAMA. 2017;318(16):1569–80. https://
doi.org/10.1001/jama.2017.7219.
20. Pai A, Melich G, Marecik SJ, Park JJ, Prasad LM. Current status of robotic surgery for rectal cancer: a bird’s eye view. J Minim Access Surg. 2015;11(1):29.
21. Pai A, Marecik SJ, Park JJ, Melich G, Sulo S, Prasad LM. Oncologic and clinicopathologic outcomes of robot-assisted total mesorectal excision for rectal can­cer. Dis Colon Rectum. 2015;58(7):659–67.
22. Pigazzi A, Luca F, Patriti A, et al. Multicentric study on robotic tumor-specic mesorectal excision for the treatment of rectal cancer. Ann Surg Oncol. 2010;17:1614–20.
23. Atallah S, Albert M, Larach S.Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24(9):2200–5.
24. Kaouk JH, Goel RK, Haber GP, Crouzet S, Stein RJ. Robotic single-port transumbilical surgery in humans: initial report. BJU Int. 2009;103(3):366–9.
25. Wren SM, Curet MJ.Single-port robotic cholecystec­tomy: results from a rst human use clinical study of the new da Vinci single-site surgical platform. Arch Surg. 2011;146(10):1122–7.
26. Kroh M, El-Hayek K, Rosenblatt S, Chand B, Escobar P, Kaouk J, Chalikonda S. First human surgery with a novel single-port robotic system: cholecystectomy using the da Vinci single-site platform. Surg Endosc. 2011;25(11):3566.
27. Atallah SB, Albert MR, deBeche-Adams TH, Larach SW. Robotic transanal minimally invasive surgery in a cadaveric model. Tech Coloproctol. 2011;15(4):
16 The Evolution ofRobotic TAMIS
163
461–4. https://doi.org/10.1007/s10151-011-0762-9. Epub 2011 Sep 28.
28. Atallah S, Keller D.Why the conventional parks trans­anal excision for early stage rectal cancer should be abandoned. Dis Colon Rectum. 2015;58(12):1211–4.
https://doi.org/10.1097/DCR.0000000000000470.
29. Moore JS, Cataldo PA, Osler T, Hyman NH.Transanal endoscopic microsurgery is more effective than tra­ditional transanal excision for resection of rectal masses. Dis Colon Rectum. 2008;51:1026–30.
30. de Graaf EJ, Burger JW, van Ijsseldijk AL, Tetteroo GW, Dawson I, Hop WC. Transanal endoscopic microsurgery is superior to transanal excision of rec­tal adenomas. Color Dis. 2011;13:762–7.
31. Christoforidis D, Cho HM, Dixon MR, Mellgren AF, Madoff RD, Finne CO. Transanal endoscopic microsurgery versus conventional transanal exci­sion for patients with early rectal cancer. Ann Surg. 2009;249:776–82.
32. Carrara A, Mangiola D, Motter M, etal. Glove port technique for transanal endoscopic microsurgery. Int J Surg Oncol. 2012;2012:383025.
33. Hompes R, Rauh SM, Hagen ME, Mortensen NJ. Preclinical cadaveric study of trans­anal endoscopic da Vinci
®
surgery. Br J Surg. 2012;99(8):1144–8. https://doi.org/10.1002/
bjs.8794. Epub 2012 May 22.
34. Atallah S. Robotic transanal minimally invasive sur­gery for local excision of rectal neoplasms (Br J Surg 2014; 101: 578–581). Br J Surg. 2014;101(5):581.
https://doi.org/10.1002/bjs.9467.
35. Marks J, Ng S, Mak T. Robotic transanal sur­gery (RTAS) with utilization of a next-generation single-port system: a cadaveric feasibility study. Tech Coloproctol. 2017;21(7):541–5. https://doi.
org/10.1007/s10151-017-1655-3. Epub 2017 Jul 14.
36. Atallah S, Parra-Davila E, DeBeche-Adams T, Albert M, Larach S. Excision of a rectal neoplasm using robotic transanal surgery (RTS): a description of the technique. Tech Coloproctol. 2012;16(5):389–92.
https://doi.org/10.1007/s10151-012-0833-6. Epub
2012 May 15.
37. Bardakcioglu O. Robotic transanal access sur­gery. Surg Endosc. 2013;27(4):1407–9. https://doi.
org/10.1007/s00464-012-2581-0. Epub 2012 Dec 13.
38. Buchs NC, Pugin F, Volonte F, Hagen ME, Morel P, Ris F. Robotic transanal endoscopic microsur­gery: technical details for the lateral approach. Dis Colon Rectum. 2013;56(10):1194–8. https://doi.
org/10.1097/DCR.0b013e3182a2ac84.
39. Martin-Perez B, Andrade-Ribeiro GD, Hunter L, Atallah S. A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech Coloproctol. 2014;18(9):775–88.
https://doi.org/10.1007/s10151-014-1148-6. Epub
2014 May 7.
40. Hompes R, Rauh SM, Ris F, Tuynman JB, Mortensen NJ. Robotic transanal minimally invasive surgery for local excision of rectal neoplasms. Br J Surg. 2014;101(5):578–81. https://doi.org/10.1002/bjs.9454.
41. Atallah S, Martin-Perez B, Parra-Davila E, deBeche­Adams T, Nassif G, Albert M, Larach S. Robotic transanal surgery for local excision of rectal neopla­sia, transanal total mesorectal excision, and repair of complex stulae: clinical experience with the rst 18 cases at a single institution. Tech Coloproctol. 2015;19(7):401–10. https://doi.org/10.1007/s10151-
015-1283-8. Epub 2015 Feb 24.
42. Vallribera Valls F, Espín Bassany E, Jiménez­Gómez LM, Ribera Chavarría J, Armengol Carrasco M. Robotic transanal endoscopic microsurgery in benign rectal tumour. J Robot Surg. 2014;8(3):277–
80. https://doi.org/10.1007/s11701-013-0429-9. Epub 2013 Aug 10.
43. Atallah S, Quinteros F, Martin-Perez B, Larach S.Robotic transanal surgery for local excision of rec­tal neoplasms. J Robot Surg. 2014;8(2):193–4. https://
doi.org/10.1007/s11701-014-0463-2. Epub 2014 Apr
22.
44. Harr JN, Obias V. Robotic-assisted transanal exci­sion of a large rectal mass–a video vignette. Color Dis. 2016;18(1):107–8. https://doi.org/10.1111/
codi.13146.
45. Erenler I, Aytac E, Bilgin IA, Baca B, Hamzaoglu I, Karahasanoglu T. Robotic transanal minimally invasive surgery (R-TAMIS) with the da Vinci Xi System– a video vignette. Color Dis. 2017;19(4):401.
https://doi.org/10.1111/codi.13638.
46. Gómez Ruiz M, Cagigas Fernández C, Alonso Martín J, Cristobal Poch L, Manuel Palazuelos C, Barredo Cañibano FJ, Gómez Fleitas M, Castillo Diego J.Robotic assisted transanal polypectomies: is there any indication? Cir Esp. 2017;95(10):601–9. https://
doi.org/10.1016/j.ciresp.2017.09.006. Epub 2017
Nov 14.
47. Atallah S, Martin-Perez B, Pinan J, Quinteros F, Schoonyoung H, Albert M, Larach S.Robotic trans­anal total mesorectal excision: a pilot study. Tech Coloproctol. 2014;18(11):1047–53. https://doi.
org/10.1007/s10151-014-1181-5. Epub 2014 Jun 24.
48. Kuo L, Ngu JC, Tong Y, etal. Combined robotic trans­anal total mesorectal excision (R-taTME) and single­site plus one-port (R-SSPO) technique for ultra-low rectal surgery—initial experience with a new opera­tion approach. Int J Color Dis. 2017;32(2):249–54.
https://doi.org/10.1007/s00384-016-2686-3.
49. Gómez Ruiz M, Parra IM, Palazuelos CM, Martín JA, Fernández CC, Diego JC, Fleitas MG.Robotic­assisted laparoscopic transanal total mesorectal excision for rectal cancer: a prospective pilot study. Dis Colon Rectum. 2015;58(1):145–53. https://doi.
org/10.1097/DCR.0000000000000265.
50. Atallah S. Assessment of a exible robotic system for endoluminal applications and transanal total mesorectal excision (taTME): could this be the solu­tion we have been searching for? Tech Coloproctol. 2017;21(10):809–14. https://doi.org/10.1007/s10151-
017-1697-6. Epub 2017 Oct 24.
51. Kuo LJ, Ngu JC, Tong YS, Chen CC. Combined robotic transanal total mesorectal excision (R-taTME)
164
S. Atallah et al.
and single-site plus one-port (R-SSPO) technique for ultra-low rectal surgery-initial experience with a new operation approach. Int J Color Dis. 2017;32(2):249–
54. https://doi.org/10.1007/s00384-016-2686-3. Epub 2016 Oct 15.
52. Laird R, Obias VJ.Robotic transanal stula repair– a video vignette. Color Dis. 2015;17(1):90. https://doi.
org/10.1111/codi.12799.
53. Stack ME, Umanskiy K. Robotic-assisted transanal repair of a rectovaginal stula. J Gastrointest Surg. 2016;20(12):2106. Epub 2016 May 24.
54. Atallah S, Nassif G, Polavarapu H, deBeche-Adams T, Ouyang J, Albert M, Larach S. Robotic-assisted transanal surgery for total mesorectal excision (RATS­TME): a description of a novel surgical approach with video demonstration. Tech Coloproctol. 2013;17(4):441–7. https://doi.org/10.1007/s10151-
013-1039-2. Epub 2013 Jun 26.
55. Gomez Ruiz M, Martin Parra I, Calleja Iglesias A, Stein H, Sprinkle S, Manuel Palazuelos C, Alonso Martin J, Cagigas Fernandez C, Castillo Diego J, Gomez Fleitas M. Preclinical cadaveric study of transanal robotic proctectomy with total mesorec­tal excision combined with laparoscopic assistance. Int J Med Robot. 2015;11(2):188–93. https://doi.
org/10.1002/rcs.1581. Epub 2014 Feb 27.
56. Atallah S, Drake J, Martin-Perez B, Kang C, Larach S. Robotic transanal total mesorectal excision with intersphincteric dissection for extreme distal rectal cancer: a video demonstration. Tech Coloproctol. 2015;19(7):435. https://doi.org/10.1007/s10151-015-
1304-7. Epub 2015 May 12.
57. Son J, Cho CN, Kim KG, Chang TY, Jung H, Kim SC, Kim MT, Yang N, Kim TY, Sohn DK.A novel semi­automatic snake robot for natural orice transluminal endoscopic surgery: preclinical tests in animal and human cadaver models (with video). Surg Endosc. 2015;29(6):1643–7. https://doi.org/10.1007/s00464-
014-3854-6. Epub 2014 Oct 8.
58. Melani AF, Diana M, Marescaux J. The quest for precision in transanal total mesorectal excision. Tech Coloproctol. 2016;20(1):11–8.
59. Hompes R. Robotics and transanal minimal inva­sive surgery (TAMIS): the “sweet spot” for robot­ics in colorectal surgery? Tech Coloproctol. 2015;19(7):377–8. https://doi.org/10.1007/s10151-
015-1326-1. Epub 2015 Jun 25.
60. Mohd Azman ZA, Kim SH.A review on robotic sur­gery in rectal cancer. Transl Gastroenterol Hepatol. 2016;1:5. https://doi.org/10.21037/tgh.2016.03.16. eCollection 2016.
Transanal Robotic Surgery andFuture Directions
KevinM.Izquierdo, ThushySiva, JeanSalem, BrigitteAnderson, andJohnMarks
Abbreviations
MIS Minimally invasive surgery NOTES Natural orice transluminal
endoscopic surgery
RATS-TME Robotic transanal total mesorec-
tal excision; robotic taTME RTAS Robotic transanal surgery SILS Single incision laparoscopic surgery TAMIS Transanal minimally invasive
surgery TATA Transanal transabdominal
proctosigmoidectomy taTME Transanal total mesorectal excision TEM Transanal endoscopic
microsurgery
K. M. Izquierdo (*) · J. Salem Lankenau Medical Center, Division of Colorectal Surgery, Wynnewood, PA, USA e-mail: salemj@mlhs.org
T. Siva Easton Hospital, Department of Surgery, Easton, PA, USA
B. Anderson · J. Marks Colon and Rectal Surgery, Lankenau Medical Center, Marks Colorectal Surgical Associates, Wynnewood, PA, USA e-mail: crresearch@mlhs.org; marksj@mlhs.org
17

Introduction

The challenges inherent to rectal cancer surgery have inspired ideological innovations in the eld. Driven by high recurrence rates and high morbid­ity seen with the earliest rectal cancer operations, and by the technical difculty of operating in the deep and narrow connes of the pelvis, the surgi­cal treatment of rectal cancer has continued to evolve. The total mesorectal excision (TME) as described by Dr. Bill Heald [1] and the transanal transabdominal proctosigmoidectomy (TATA) as described by Dr. Gerald Marks [2], which ensures a clear distal margin in the rectum pre-treated with radiation, have both become core oncologic tenets of rectal cancer surgery. Furthermore, the TATA allows sphincter preservation, even for patients with low rectal cancers, without sacric­ing the quality of oncologic outcomes [3]. Combined with TEM, these concepts have given rise to the transanal total mesorectal excision (taTME).
Benets and advances in minimally invasive surgery (MIS) have been applied successfully to rectal cancer surgery. Prior to the 1980s, trans­anal excision of rectal neoplasms was restricted by limited reach and exposure. In 1983, Dr. Gerhard Buess invented transanal endoscopic microsurgery (TEM) [4], setting the stage for a long technological evolution in rectal surgery. Building off of Dr. Buess’ TEM technique, the
© Springer Nature Switzerland AG 2019 S. Atallah (ed.), Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME), https://doi.org/10.1007/978-3-030-11572-2_17
165
166
K. M. Izquierdo et al.
applications of transanal surgery have been extended by Atallah, Albert, and Larach using single-port transanal laparoscopy, today known as transanal minimally invasive surgery (TAMIS); and most recently, robotic surgical technology is applied transanally (Robotic TAMIS). By addressing many of the technical challenges that have hindered wider adoption of TEM, TAMIS, and taTME, robotic transanal surgery promises to increase surgeon access to these techniques so that more patients can benet. Future directions of transanal robotic surgery will undoubtedly lead to a new era of pure natural orice translu­minal endoscopic surgery (NOTES), the ultimate in minimally invasive surgery.
Evolution ofTransanal Surgery
Dr. Gerhard Buess’ transanal endoscopic micro­surgery (TEM) platform in 1983 represented a disruptive change in surgical approach and tech­nology. TEM predates laparoscopy – the rst demonstration of the laparoscopic cholecystec­tomy was presented in 1989 at the Surgical Association of Gastrointestinal and Endoscopic Surgeons (SAGES) conference by Drs. Perissat and Mouiel [5, 6]. In 1983, open surgery was the only approach in the surgical treatment of rectal cancer. The original application of TEM was in the removal of rectal polyps and was later expanded to treating malignant lesions with local excision. Although unpublished, it is believed that in 2008 Dr. John Marks performed the rst transanal total mesorectal excision (taTME) using the TEM platform.
Key technological features of TEM are bin­ocular stereotactic optics, improved access to more proximal lesions, and incisionless natural orice surgery via the anus. As applications of TEM expanded to T1 cancers, the technical advantages became evident with signicantly lower recurrence rates as compared to open trans­anal approaches. Experiences at the University of Minnesota and the Cleveland Clinic reported local recurrence rates of 4.2–9% with TEM com­pared to 25–33% with conventional transanal excision for T1 rectal cancers [7, 8]. This disrup­tive transanal minimally invasive approach set
the stage for the rapid evolution of technology in colorectal surgery over the next three decades. However, the steep learning curve and signicant cost were major barriers to its universal adoption.
Transanal minimally invasive surgery (TAMIS), rst described in 2009 by Drs. Atallah, Albert, and Larach, is a cost-effective alternative to TEM [9]. Building upon TEM concepts, TAMIS uses a exible single incision laparo­scopic surgery (SILS) port transanally rather than the rigid proctoscope used in TEM. Cost is decreased by avoiding the large start-up cost of TEM equipment and through the use of laparo­scopic instrumentation readily available in modern- day operating rooms. Atallah etal. pub­lished their experience with TAMIS in the exci­sion of both malignant and benign lesions of the rectum, and early data suggests that oncologic outcomes are comparable to TEM [10].
From a technical standpoint, TAMIS, allows access to the full 360 degrees of the lumen, whereas with TEM, the workspace is limited to the lower 180 degrees of the visualized operative eld. Furthermore, the exible platform allows better access to more proximal structures, allow­ing its application to expand to complete trans­anal total mesorectal excision. However, TAMIS initially suffered from the lack of a stable pneu­matic platform that TEM provides. Drs. Lacy, Rattner, and Sylla published a systematic study of the transanal total mesorectal excision using the TAMIS platform [11]. In doing so, they suc­cessfully melded the core principles of TATA, hybrid NOTES, and TAMIS.
Pushing the limits of transanal surgery using the TAMIS technique, Dr. Leroy pioneered “pure” NOTES proctosigmoidectomy with trans­anal completion of the TME dissection, release of the splenic exure, transection of the inferior mesenteric vessels, and coloanal anastomosis. He coined the procedure perirectal oncologic gate­way for retroperitoneal endoscopic single site surgery (PROGRESSS) [12]. Select centers have further pioneered pure NOTES taTME [13, 14].
As it was with TEM for local excision of rec­tal lesions, a steep learning curve is the primary obstacle to wider adoption of pure NOTES for rectal cancer as it requires the highest level of